PHASE II STUDY OF BEVACIZUMAB AND TEMSIROLIMUS IN PATIENTS WITH PROGRESSIVE GLIOBLASTOMA MULTIFORME AFTER PRIOR BEVACIZUMAB TREATMENT

被引：0
|
作者：
Gaziel, Tine B. [1 ]
Soerensen, Morten [1 ]
Hasselbalch, Benedikte [1 ]
Poulsen, Hans Skovgaard [1 ]
Lassen, Ulrik [1 ]
机构：
[1] Rigshosp, Dept Oncol, Copenhagen, Denmark
来源：
NEURO-ONCOLOGY | 2010年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：40 / 40
页数：1
相关论文
共 50 条
  • [1] Phase II Study of Bevacizumab and Temsirolimus Combination Therapy for Recurrent Glioblastoma Multiforme
    Lassen, Ulrik
    Sorensen, Morten
    Gaziel, Tine Bernhardtsen
    Hasselbalch, Benedikte
    Poulsen, Hans Skovgaard
    [J]. ANTICANCER RESEARCH, 2013, 33 (04) : 1657 - 1660
  • [2] Phase II study of bevacizumab and erlotinib in patients with recurrent glioblastoma multiforme
    Sathornsumetee, S.
    Vredenburgh, J. J.
    Rich, J. N.
    Desjardins, A.
    Quinn, J. A.
    Mathe, A. E.
    Gururangan, S.
    Friedman, A. H.
    Friedman, H. S.
    Reardon, D. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] PHASE II STUDY OF BEVACIZUMAB AND ERLOTINIB IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME
    Reardon, David A.
    Sathornsumetee, Sith
    Vredenburgh, James J.
    Rich, Jeremy N.
    Desjardins, Annick
    Quinn, Jennifer A.
    Mathe, Alyssa
    Gururangan, Sridharan
    Friedman, Allen H.
    Friedman, Henry S.
    [J]. NEURO-ONCOLOGY, 2009, 11 (02) : 231 - 231
  • [4] Phase II study of border zone stereotactic radiosurgery with bevacizumab in patients with recurrent or progressive glioblastoma multiforme
    Megan Mantica
    Jan Drappatz
    Frank Lieberman
    Constantinos G. Hadjipanayis
    L. Dade Lunsford
    Ajay Niranjan
    [J]. Journal of Neuro-Oncology, 2023, 164 : 179 - 190
  • [5] Phase II study of border zone stereotactic radiosurgery with bevacizumab in patients with recurrent or progressive glioblastoma multiforme
    Mantica, Megan
    Drappatz, Jan
    Lieberman, Frank
    Hadjipanayis, Constantinos G. G.
    Lunsford, L. Dade
    Niranjan, Ajay
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2023, 164 (1) : 179 - 190
  • [6] Phase II study of border zone stereotactic radiosurgery with bevacizumab in patients with recurrent or progressive glioblastoma multiforme.
    Mantica, Megan
    Drappatz, Jan
    Lunsford, L. Dade
    Lieberman, Frank S.
    Niranjan, Ajay
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] RESPONSE OF PROGRESSIVE PEDIATRIC BIFRONTAL GLIOBLASTOMA MULTIFORME TO A COMBINATION OF TARGETED THERAPY USING TEMSIROLIMUS AND BEVACIZUMAB
    Pearlman, Michael L.
    Sadighi, Zsila
    Bingham, Rachel
    Vats, Trib
    Khatua, Soumen
    [J]. NEURO-ONCOLOGY, 2011, 13 : 96 - 97
  • [8] Phase II Study of Bevacizumab in Combination With Temozolomide as Treatment of Patients With Recurrent Glioblastoma Multiforme: Preliminary Analysis of Toxicity
    Sepulveda, J.
    Belda, C.
    Balana, C.
    Perez Segura, P.
    Reynes, G.
    Gil, M.
    Gallego, O.
    Berrocal, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S589 - S589
  • [9] A randomized phase II study of carboplatin and bevacizumab in recurrent glioblastoma multiforme (CABARET)
    Field, Kathryn Maree
    Simes, John
    Wheeler, Helen
    Hovey, Elizabeth J.
    Nowak, Anna K.
    Cher, Lawrence
    Brown, Chris
    Livingstone, Ann
    Sawkins, Kate
    Rosenthal, Mark
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] A RANDOMIZED PHASE II STUDY OF CARBOPLATIN AND BEVACIZUMAB IN RECURRENT GLIOBLASTOMA MULTIFORME ( CABARET STUDY)
    Field, Kathryn M.
    Cher, Lawrence
    Wheeler, Helen
    Hovey, Elizabeth
    Nowak, Anna K.
    Simes, John
    Sawkins, Kate
    France, Trevor
    Brown, Chris
    [J]. NEURO-ONCOLOGY, 2011, 13 : 88 - 88
12345